InvestorsHub Logo
Followers 6
Posts 136
Boards Moderated 0
Alias Born 05/08/2014

Re: Pyrrhonian post# 37321

Friday, 07/10/2015 2:07:06 PM

Friday, July 10, 2015 2:07:06 PM

Post# of 725420
So, NWBO uses pretty much the same language to introduce all of their patents, thus I think it is difficult to pinpoint exactly which Patent "removes" the IL-4 effect you were describing.

http://www.sec.gov/Archives/edgar/data/1072379/000114420414061989/filename1.htm

In the above link, it clearly states that the FDA has already approved and NWBO is already using these techniques in their current trials. Also, with regards to maturation of Dendritic Cells, some of those were issued back in 2012 if not earlier.

These 2 links have almost the exact same wording ...
http://www.nwbio.com/nw-bios-patent-portfolio-further-expanded-with-manufacturing-automation-patent/

http://www.nwbio.com/nw-bio-receives-u-s-patent-on-broad-processes-for-producing-more-potent-dendritic-cells/

To me it seems like the overall manufacturing process is soo different from what is currently industry standard (from maturation, to biochemicals, to filtration, etc.). Thus, it is not fair to compare anything that NWBO does against the other studies. It is not just 1 thing that is different, it is many.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News